LivaNova Names Lucile Blaise Global Head of Commercialization for Obstructive Sleep Apnea

Reuters
2025.12.02 14:01
portai
I'm PortAI, I can summarize articles.

LivaNova PLC has appointed Lucile Blaise as Global Head of Commercialization for Obstructive Sleep Apnea, effective December 1. Blaise joins the Executive Leadership Team, reporting to CEO Vladimir Makatsaria, bringing over 25 years of medtech experience.

LivaNova PLC has appointed Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise joins the company’s Executive Leadership Team and will report to Chief Executive Officer Vladimir Makatsaria. She brings over 25 years of experience in the medtech sector, previously holding leadership roles at ResMed and other healthcare companies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livanova plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20251202334791) on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer